AS

Ankur Sachdeva

Active Director Director DIN 08481257
DIN 08481257 First appointment Jun 2019 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Ankur Sachdeva

Data last updated:

Ankur Sachdeva is a Director at Cadmed Pharmaceuticals Private Limited (since 2019). The company operates in Business Services. Cadmed Pharmaceuticals Private Limited reported revenue of ₹1.5 Lakh (FY 2022).

DIN 08481257
Primary Designation Director
Industry Business Services
First Appointment 13 Jun 2019
Oldest Company Age 11 yrs
Largest company Cadmed Pharmaceuticals Private Limited · ₹1.5 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jun 20192015₹1.5 Lakh (FY 2022)Active

Board colleagues of Ankur Sachdeva

Directorship timeline

Open interactive timeline →
Cadmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankur Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Sachdeva

Ankur Sachdeva currently holds 1 directorship: Cadmed Pharmaceuticals Private Limited (Director, since 13 Jun 2019, revenue ₹1.5 Lakh (FY 2022)).

Ankur Sachdeva was first appointed on 13 Jun 2019 as Director at Cadmed Pharmaceuticals Private Limited.

The current boards of Ankur Sachdeva's companies include Anuj Kumar Pathak (Cadmed Pharmaceuticals Private Limited), Chandini Sachdeva (Cadmed Pharmaceuticals Private Limited), Daksh Bhatia (Cadmed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available